Iuliu Hatieganu University Of Medicine And Pharmacy

This study tests remimazolam, a new ultra-short-acting sedative, in 200 elderly patients (65+) with serious health conditions like severe lung disease or organ failure. The goal is to see if it provides more stable heart rate and blood pressure, less breathing problems, and faste…